SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-21-005818
Filing Date
2021-02-01
Accepted
2021-02-01 17:08:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS f424b50121_biondvaxpharma.htm 424B5 1190429
2 GRAPHIC tbiond_logo.jpg GRAPHIC 42838
  Complete submission text file 0001213900-21-005818.txt   1250539
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-240189 | Film No.: 21577673
SIC: 2836 Biological Products, (No Diagnostic Substances)